IP Library › Granted Patent US 11,247,045
Granted Patent B2
US 11,247,045 · App. 16/759,257 · Granted Feb 15, 2022

Systems and methods for delivering neuroregenerative therapy

Inventors: Michael Patrick Willand (Oakville, CA); Sergio David Aguirre (Mississauga, CA)
Assignee: Epineuron Technologies Inc.
A61N1/0556A61N1/36125A61N1/36171
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,247,045
App. No.
16/759,257
Granted
Feb 15, 2022
Kind
B2
Abstract

Systems, devices and methods are disclosed for the treatment of injured peripheral nerves or other tissue using electrical stimulation. The systems can be used either in intraoperative or peri-operative settings and incorporate the use of either a plurality of monopolar electrodes with a patch used as return or a plurality of bipolar electrodes such as a cuff. The systems can provide hands-free delivery of electrical stimulation therapy over a predetermined set of time.

Claims (34)

1. A method of enhancing neuroregeneration in a subject, comprising:

during a first phase, delivering stimulation energy of a first frequency to a target peripheral nerve of the subject via at least one electrode assembly; and

during a second phase, delivering to the subject stimulation energy of a second frequency for a predetermined period via the at least one electrode assembly;

wherein the at least one electrode assembly is configured to be percutaneously positioned adjacent the target peripheral nerve during both the first phase and the second phase;

wherein the at least one electrode assembly is configured to be placed at a location within the subject using a percutaneous pathway;

wherein the at least one electrode assembly is configured to be removed from the subject using the percutaneous pathway following the delivery of stimulation energy;

wherein delivering stimulation energy to the subject during the second phase creates a regenerative effect to the target peripheral nerve; and

wherein delivering stimulation energy during the first phase is configured to confirm at least one validation condition.

2. The method of claim 1 ,

wherein the at least one validation condition is that the at least one electrode assembly is working;

wherein the second frequency is greater than the first frequency;

wherein the first frequency is 1 Hz to 10 Hz; and

wherein the second frequency is 1 Hz to 100 Hz.

3. The method of claim 1 , wherein the second frequency is greater than the first frequency.

4. The method of claim 1 , wherein the at least one validation condition is that the at least one electrode assembly is working.

5. The method of claim 4 , wherein delivering stimulation energy during the first phase is configured to activate an indicator that the at least one electrode assembly is working.

6. The method of claim 1 , wherein the first frequency is 1 Hz to 10 Hz, and wherein the second frequency is 10 Hz to 100 Hz.

7. The method of claim 1 , wherein the second frequency is 1 Hz to 100 Hz.

8. The method of claim 1 , wherein confirming the at least one validation condition comprises detecting a motor or a sensory response in the subject.

9. The method of claim 1 , wherein confirming the at least one validation condition comprises measuring an electrical parameter.

10. The method of claim 1 , wherein the at least one electrode assembly is configured to at least partially surround the target peripheral nerve prior to the delivery of stimulation energy.

11. A method of enhancing neuroregeneration in a subject, comprising:

delivering stimulation energy to a target peripheral nerve of the subject via at least one electrode assembly to confirm at least one validation condition; and

delivering to the subject stimulation energy via the at least one electrode assembly to create a regenerative effect to the target peripheral nerve;

wherein the at least one electrode assembly is configured to be placed at a location within the subject using a percutaneous pathway; and

wherein the at least one electrode assembly is configured to be percutaneously positioned adjacent the target peripheral nerve while confirming the at least one validation condition and while creating a regenerative effect; and

wherein the at least one electrode assembly is configured to be removed from the subject using the percutaneous pathway following the delivery of stimulation energy.

12. The method of claim 11 , wherein a frequency of the stimulation energy to confirm at least one validation condition is 1 Hz to 10 Hz.

13. The method of claim 11 , wherein a frequency of the stimulation energy to create the regenerative effect is 1 Hz to 100 Hz.

14. The method of claim 11 , wherein a frequency of the stimulation energy to confirm at least one validation condition is 1 Hz to 10 Hz, and wherein a frequency of the stimulation energy to create the regenerative effect is 1 Hz to 100 Hz.

15. The method of claim 11 , wherein confirming the at least one validation condition is that the at least one electrode assembly is working.

16. The method of claim 11 , wherein confirming the at least one validation condition includes detecting a motor or a sensory response in the subject.

17. The method of claim 11 , wherein confirming the at least one validation condition includes measuring an electrical parameter.

18. The method of claim 11 , wherein the at least one electrode assembly is configured to at least partially surround the target peripheral nerve prior to the delivery of stimulation energy.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2021
From: WILLAND, MICHAEL PATRICK; AGUIRRE, SERGIO DAVID
To: EPINEURON TECHNOLOGIES INC.
Reel/Frame 058208/0792 →
Continuity (3)
Provisional Application 62683019 · Jun 11, 2018
Provisional Application 62577141 · Oct 25, 2017
Related Publication 20200338338A1 · Oct 29, 2020
Cited By (3)
US 12,318,608 US 12,611,538 US 12,616,832